Page last updated: 2024-08-25

bromopyruvate and fluorodeoxyglucose f18

bromopyruvate has been researched along with fluorodeoxyglucose f18 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acha-Ngwodo, O; Buijs, M; Engles, JM; Geschwind, JF; Ishimori, T; Vali, M; Vossen, JA; Wahl, RL1
Acha-Ngwodo, O; Buijs, M; Engles, JM; Ganapathy-Kanniappan, S; Geschwind, JF; Khwaja, A; Liapi, E; Shanmugasundaram, G; Syed, L; Vali, M; Ventura, VP; Vossen, JA; Wahl, RL1
Buijs, M; Ganapathy, S; Ganapathy-Kanniappan, S; Geschwind, JF; Khwaja, AA; Liapi, E; Prieto-Ventura, V; Vali, M; Vossen, JA; Wahl, RL1
Corbin, DJ; Ko, YH; Lee, MJ; Pedersen, PL; Verhoeven, HA; Vogl, TJ1
Guo, XY; Lu, YF; Wang, TA; Xian, SL; Zhang, XD1

Other Studies

5 other study(ies) available for bromopyruvate and fluorodeoxyglucose f18

ArticleYear
Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer.
    Investigational new drugs, 2009, Volume: 27, Issue:2

    Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glycolysis; Mammary Neoplasms, Experimental; Pyruvates; Rats; Rats, Inbred Lew

2009
Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 327, Issue:1

    Topics: Animals; Carbon Radioisotopes; Fluorodeoxyglucose F18; Infusions, Intra-Arterial; Liver Neoplasms, Experimental; Pyruvates; Rabbits; Tissue Distribution

2008
Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:2

    Topics: Angiography; Animals; Enzyme Inhibitors; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Infusions, Intra-Arterial; Liver; Liver Circulation; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Pharmaceutical Solutions; Positron-Emission Tomography; Pyruvate Dehydrogenase Complex; Pyruvates; Rabbits; Radiopharmaceuticals; Tomography, Emission-Computed

2011
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.
    Journal of bioenergetics and biomembranes, 2012, Volume: 44, Issue:1

    Topics: Adolescent; Ammonia; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Energy Metabolism; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Molecular Structure; Positron-Emission Tomography; Pyruvates; Translational Research, Biomedical; Urea; Uric Acid

2012
Combined 18F-FDG PET/CT imaging and a gastric orthotopic xenograft model in nude mice are used to evaluate the efficacy of glycolysis-targeted therapy.
    Oncology reports, 2018, Volume: 39, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Citrates; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Positron Emission Tomography Computed Tomography; Pyruvates; Random Allocation; Sodium Citrate; Stomach Neoplasms; Treatment Outcome; Xenograft Model Antitumor Assays

2018